Pemphigus is an autoimmune bullous disease, in which autoantibodies react with the cell–cell adhesion structures, desmosomes, causing blisters and erosions on the oral mucosa and skin. Pemphigus ...

pemphigus vegetans, and paraneoplastic pemphigus, is based primarily on histology, serology, and clinical presentation. Other conditions that must be differentiated from PV and may present with ...

Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut allergy was not achieved, according to study results. Image: Adobe Stock ...

Pemphigus encompasses a heterogeneous group of autoimmune blistering diseases, which affect both mucous membranes and the skin. The disease usually runs a chronic-relapsing course, with a potentially ...

He was instructed to continue the prednisone with an extended-taper dosing schedule in place. The onset and course of pemphigus vulgaris depend on the interaction between predisposing and inducing ...

Skin diseases are pathologic conditions that affect the body's surfaces (also called the integument), including skin, hair, nails and associated glands. They can involve all layers of the skin and ...

Dupilumab vs conventional AD therapies had less risk for anxiety, depression, and adjustment and sleep disorders, especially among Black patients. Patients with atopic dermatitis (AD) who were ...

Department of Rheumatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Pemphigus vegetans (P Veg), the rarest subtype of pemphigus, is characterized by ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase III for Bullous Pemphigoid. According to GlobalData, Phase III drugs for Bullous Pemphigoid does not have ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached over $13bn in global sales, which affirms its commercial advantage and sets a milestone for ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis ...

Clinicians should consider this treatable disorder in the differential diagnosis of vCJD. CSF, cerebrospinal fluid MRI, magnetic resonance imaging PLE, paraneoplastic limbic encephalitis vCJD, variant ...